Vetter Starts Operations in Its Center for Visual Inspection and Logistics

Article

Vetter expanded visual inspection facilities and controlled-temperature storage at its Ravensburg Vetter West facility in Germany.

Vetter has begun operations in its expanded Visual Inspection and Logistics Center located in Ravensburg, Germany, the company announced on Jan. 25, 2017. The company invested approximately 100 million Euros ($107 million) in the expansion at the site, which was initially put into operation five years ago. The new capacity encompasses final product inspection and logistics, with more than double the previous capacity for quality control, cold-storage, and room-temperature storage.

The expanded center, referred to as Ravensburg Vetter West, is located on approximately 50,000 m2 of floor space and offers a 35,000-pallet warehouse capacity for storing pharmaceuticals in refrigeration or room temperature conditions. Capacities for chest freezers, incubation chambers, and constant climate chambers have also been increased, as have the visual inspection capacities of filled units in either manual or automatic mode. The center also contains a support materials warehouse with corresponding safety installations as well as a new packaging-check laboratory and the company’s central archive. Additionally, the number of office workspaces were increased. By the end of 2017, the contract development and manufacturing organization (CDMO) will relinquish its existing Holbeinstrasse site for visual inspection and logistics. Its employees and departments will gradually be relocated to Ravensburg Vetter West, resulting in a working staff of approximately 800 employees.

“The requirements regarding final product inspection as well as transportation and storage of (bio-) pharmaceutical materials are ever-increasing,” said Vetter Managing Director Thomas Otto, in the press release. “Concentrating our supply-chain processes in one site enables bundled resources for even more efficient and highly-secured logistic and quality control procedures.”

Source: Vetter

Recent Videos
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
© 2024 MJH Life Sciences

All rights reserved.